Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke "SWIFT DIRECT"

Recruiting

Phase N/A Results N/A

Summary of Purpose

Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA) has been the only proven therapy for acute ischemic stroke (AIS) for almost 20 years. Whether IV t-PA prior to endovascular clot retrieval is beneficial for AIS patients with a proximal vessel occlusion in the anterior circulation has currently become a matter of debate and is a relevant unanswered question in clinical practice....

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 November 2017.

14 Nov 2017 12 Jun 2017 31 Dec 2020 31 Dec 2021 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts